Cybin Announces Promising Results from Feasibility Study Measuring Psychedelic Effects on the Brain
Psychedelic therapy is gaining ground in the psychiatric and medical community. After what was essentially a ban on scientific study of hallucinogenic compounds for over three decades, new data are […]
How Does Ketamine Affect the Brain Over Time? Kernel Founder Tests his Invention
Kernel, a non-invasive neuroimaging company, and Cybin Inc. (NYSE American: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics,” have announced results from an innovative study involving ketamine and […]
5 Things to Know With Your Morning Coffee — Thursday, June 17, 2021
Every day we wake up, drink a cup of coffee, and get ready for work. Following are a handful of stories from around the tech world condensed to fit into […]
Cybin Inc. Partners with Kernel’s Flow To Quantify Brain Activity During Therapy
According to The World Health Organization (WHO), one in four people in the world will be affected by mental or neurological disorders at some point in their lives. The COVID-19 […]